Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
40
Number of overlapping holdings
18.7%
% of BTEC's 220 holdings also in CNCR
53.3%
% of CNCR's 75 holdings also in BTEC
Overlap by Weight
Sector Drift (BTEC minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BTEC |
Weight in CNCR |
Overlap | |
---|---|---|---|---|
BLUEPRINT MEDICINES CORP. | 1.4% | 1.4% | 1.4% | |
NUVALENT, INC. CLASS A | 1.1% | 1.0% | 1.0% | |
IOVANCE BIOTHERAPEUTICS INC | 1.0% | 1.1% | 1.0% | |
SPRINGWORKS THERAPEUTICS, INC. | 0.8% | 1.1% | 0.8% | |
ARCELLX, INC. | 0.8% | 1.0% | 0.8% |
Position Highlights (Non-Overlapping Exposures)
BTEC Overweight Relative to CNCR
KARUNA THERAPEUTICS, INC. | 2.7% | |
SAREPTA THERAPEUTICS INC | 2.6% | |
EXACT SCIENCES CORP | 2.4% | |
NATERA INC | 2.3% | |
ALNYLAM PHARMACEUTICALS INC | 2.3% | |
BIO-RAD LABORATORIES-CL A | 2.2% | |
ILLUMINA INC | 2.0% | |
ELANCO ANIMAL HEALTH, INC. | 1.8% | |
CYTOKINETICS INC | 1.7% | |
APELLIS PHARMACEUTICALS, INC. | 1.7% |
BTEC Underweight Relative to CNCR
GERON CORP | -2.7% | |
ACRIVON THERAPEUTICS, INC. | -2.6% | |
ENLIVEN THERAPEUTICS, INC. | -2.1% | |
JANUX THERAPEUTICS, INC. | -1.8% | |
NUVATION BIO INC CLASS A | -1.7% | |
2SEVENTY BIO, INC. | -1.5% | |
MERCK & CO. INC. | -1.5% | |
MORPHOSYS AG SPONSORED ADR | -1.4% | |
EXELIXIS INC | -1.4% | |
ITEOS THERAPEUTICS, INC. | -1.4% |